Division of Infectious Diseases, Department of Internal Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea.
Department of Infectious Diseases, Ajou University School of Medicine, Suwon, Republic of Korea.
J Hosp Infect. 2023 Aug;138:52-59. doi: 10.1016/j.jhin.2023.05.010. Epub 2023 Jun 3.
The coronavirus disease 2019 (COVID-19) pandemic has influenced hospital infection control practices.
To evaluate the impact of the COVID-19 pandemic on healthcare-associated infections (HAIs) in intensive care units (ICUs).
A retrospective analysis using data from the Korean National Healthcare-Associated Infections Surveillance System was conducted. Comparisons between incidence rates and micro-organism distributions of bloodstream infection (BSI), central line-associated bloodstream infections (CLABSI), catheter-associated urinary tract infection (CAUTI), and ventilator-associated pneumonia (VAP) before and during the COVID-19 pandemic were performed according to hospital size.
The incidence rate of BSI significantly decreased during the COVID-19 pandemic compared to the pre-COVID-19 period (1.38 vs 1.23 per 10,000 patient-days, relative change -11.5%; P < 0.001). The incidence rate of VAP (1.03 vs 0.81 per 1000 device-days, relative change -21.4%; P < 0.001) significantly decreased during the COVID-19 pandemic compared to the pre-COVID-19 period, whereas rates of CLABSI (2.30 vs 2.23 per 1000 device-days; P = 0.19) and CAUTI (1.26 vs 1.26 per 1000 device-days; P = 0.99) were similar between the two periods. The rates of BSI and CLABSI significantly increased during the COVID-19 pandemic compared to the pre-COVID-19 period in large-sized hospitals, whereas these rates significantly decreased in small-to-medium-sized hospitals. The rates of CAUTI and VAP significantly decreased in small-sized hospitals. There were no significant changing trends in the rates of multidrug-resistant pathogens isolated from patients with HAI between the two periods.
The incidence rates of BSI and VAP in ICUs decreased during the COVID-19 pandemic compared to the pre-COVID-19 period. This decrease was mainly seen in small-to-medium-sized hospitals.
2019 年冠状病毒病(COVID-19)大流行影响了医院感染控制措施。
评估 COVID-19 大流行对重症监护病房(ICU)中与医疗保健相关的感染(HAI)的影响。
使用韩国国家医疗保健相关感染监测系统的数据进行回顾性分析。根据医院规模,比较 COVID-19 大流行前后血流感染(BSI)、中心静脉相关血流感染(CLABSI)、导管相关尿路感染(CAUTI)和呼吸机相关肺炎(VAP)的发生率和微生物分布。
与 COVID-19 大流行前相比,BSI 的发生率在 COVID-19 大流行期间显著降低(每 10000 患者日 1.38 与 1.23,相对变化-11.5%;P<0.001)。与 COVID-19 大流行前相比,VAP 的发生率(每 1000 设备日 1.03 与 0.81,相对变化-21.4%;P<0.001)在 COVID-19 大流行期间显著降低,而 CLABSI 的发生率(每 1000 设备日 2.30 与 2.23;P=0.19)和 CAUTI 的发生率(每 1000 设备日 1.26 与 1.26;P=0.99)在两个时期相似。与 COVID-19 大流行前相比,大医院的 BSI 和 CLABSI 的发生率在 COVID-19 大流行期间显著增加,而中小医院的这些发生率则显著降低。小型医院的 CAUTI 和 VAP 发生率显著降低。两个时期从 HAI 患者中分离的多药耐药病原体的发生率均无明显变化趋势。
与 COVID-19 大流行前相比,ICU 中 BSI 和 VAP 的发生率在 COVID-19 大流行期间降低。这种下降主要发生在中小医院。